Han, J.-H
Who may want a more detailed discussion This topic becomes more relevant when weight-loss treatment needs to feel medically structured, easier to follow, and better matched to real-world routines
on thyroid hormones in rats
Toxin Rev 39:115122 McGill MR (2016) The past and present of serum aminotransferases and the future of liver injury biomarkers

Class Examples named by WADA Status GHRH analogs CJC-1293, CJC-1295, sermorelin, tesamorelin S2 prohibited at all times GH secretagogues and mimetics Anamorelin, capromorelin, ibutamoren (MK-677), ipamorelin, lenomorelin (ghrelin), macimorelin, tabimorelin S2 prohibited at all times GH-releasing peptides (GHRPs) Alexamorelin, examorelin (hexarelin), GHRP-1, GHRP-2 (pralmorelin), GHRP-3, GHRP-4, GHRP-6 S2 prohibited at all times Erythropoietin and EPO-receptor agonists Erythropoietins and agents affecting erythropoiesis S2 prohibited at all times Growth hormone and growth factors Growth hormone, IGF-1 and its analogs, and related growth factors affecting muscle, tendon or ligament S2 prohibited at all times Unapproved experimental peptides BPC-157 and similar compounds with no regulatory approval S0 prohibited at all times The S0 point is the one most often missed